Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy

Immunotherapy, Ahead of Print.

Source: Immunotherapy - March 7, 2023 Category: Allergy & Immunology Authors: Xichen Zheng Jiajie Kuai Guanghui Shen Source Type: research